224 related articles for article (PubMed ID: 12200703)
21. High frequency of t(14;18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas: improved polymerase chain reaction protocols for their detection.
Albinger-Hegyi A; Hochreutener B; Abdou MT; Hegyi I; Dours-Zimmermann MT; Kurrer MO; Heitz PU; Zimmermann DR
Am J Pathol; 2002 Mar; 160(3):823-32. PubMed ID: 11891181
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of screening the intermediate cluster region of the bcl2 gene in follicular lymphomas by PCR.
Batstone PJ; Goodlad JR
J Clin Pathol; 2005 Jan; 58(1):81-2. PubMed ID: 15623489
[TBL] [Abstract][Full Text] [Related]
23. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
Limpens J; de Jong D; van Krieken JH; Price CG; Young BD; van Ommen GJ; Kluin PM
Oncogene; 1991 Dec; 6(12):2271-6. PubMed ID: 1766674
[TBL] [Abstract][Full Text] [Related]
24. Real-Time t(14;18)(q32;q21) PCR assay combined with high-resolution capillary electrophoresis: a novel and rapid approach that allows accurate quantitation and size determination of bcl-2/JH fusion sequences.
Sanchez-Vega B; Vega F; Hai S; Medeiros LJ; Luthra R
Mod Pathol; 2002 Apr; 15(4):448-53. PubMed ID: 11950920
[TBL] [Abstract][Full Text] [Related]
25. BCL2 complex rearrangement in follicular lymphoma: translocation mbr/JH and deletion in the vcr region of the same BCL2 allele.
Séité P; Hillion J; d'Agay MF; Berger R; Larsen CJ
Oncogene; 1993 Nov; 8(11):3073-80. PubMed ID: 8414508
[TBL] [Abstract][Full Text] [Related]
26. The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas.
Adam P; Baumann R; Schmidt J; Bettio S; Weisel K; Bonzheim I; Fend F; Quintanilla-Martínez L
Hum Pathol; 2013 Sep; 44(9):1817-26. PubMed ID: 23642737
[TBL] [Abstract][Full Text] [Related]
27. Is t(14;18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients.
Godon A; Moreau A; Talmant P; Baranger-Papot L; Geneviève F; Milpied N; Zandecki M; Avet-Loiseau H
Leukemia; 2003 Jan; 17(1):255-9. PubMed ID: 12529690
[TBL] [Abstract][Full Text] [Related]
28. Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma.
López-Guillermo A; Cabanillas F; McDonnell TI; McLaughlin P; Smith T; Pugh W; Hagemeister F; Rodríguez MA; Romaguera JE; Younes A; Sarris AH; Preti HA; Lee MS
Blood; 1999 May; 93(9):3081-7. PubMed ID: 10216105
[TBL] [Abstract][Full Text] [Related]
29. Polymerase chain reaction based gene rearrangement studies in the diagnosis of follicular lymphoma--performance in formaldehyde-fixed tissue and application in clinical problem cases.
Miettinen M; Lasota J
Pathol Res Pract; 1997; 193(1):9-19. PubMed ID: 9112269
[TBL] [Abstract][Full Text] [Related]
30. [Detection of t(14;18) chromosome translocation in follicular lymphoma by polymerase chain reaction].
Takács I; Radványi G; Szegedi G; Matolcsy A; Semsei I
Orv Hetil; 1997 May; 138(18):1129-32. PubMed ID: 9182282
[TBL] [Abstract][Full Text] [Related]
31. Quantification of bcl-2/JH fusion sequences and a control gene by multiplex real-time PCR coupled with automated amplicon sizing by capillary electrophoresis.
Sanchez-Vega B; Vega F; Medeiros LJ; Lee MS; Luthra R
J Mol Diagn; 2002 Nov; 4(4):223-9. PubMed ID: 12411590
[TBL] [Abstract][Full Text] [Related]
32. Neoplastic cells do not carry bcl2-JH rearrangements detected in a subset of primary cutaneous follicle center B-cell lymphomas.
Vergier B; Belaud-Rotureau MA; Benassy MN; Beylot-Barry M; Dubus P; Delaunay M; Garroste JC; Taine L; Merlio JP
Am J Surg Pathol; 2004 Jun; 28(6):748-55. PubMed ID: 15166666
[TBL] [Abstract][Full Text] [Related]
33. Derivative (3)t(3;18)(q27;q21)t(18;16)(q21;?) involving the BCL2 and BCL6 genes in follicular lymphoma with t(3;14;18)(q27;q32;q21).
Yamamoto K; Ono K; Katayama Y; Shimoyama M; Matsui T
Cancer Genet Cytogenet; 2007 Nov; 179(1):69-75. PubMed ID: 17981218
[TBL] [Abstract][Full Text] [Related]
34. Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes.
Horsman DE; Okamoto I; Ludkovski O; Le N; Harder L; Gesk S; Siebert R; Chhanabhai M; Sehn L; Connors JM; Gascoyne RD
Br J Haematol; 2003 Feb; 120(3):424-33. PubMed ID: 12580956
[TBL] [Abstract][Full Text] [Related]
35. Follicular lymphoma in Taiwan: a low frequency of t(14;18), with grade 3A tumours more closely related to grade 3B than to low-grade tumours.
Chang ST; Lu YH; Lu CL; Kuo SY; Liu H; Lin SH; Win KT; Hsieh YC; Chuang SS
Histopathology; 2013 Jul; 63(1):1-12. PubMed ID: 23631722
[TBL] [Abstract][Full Text] [Related]
36. Sensitive and reproducible detection of occult disease in patients with follicular lymphoma by PCR amplification of t(14;18) both pre- and post-treatment.
Berinstein NL; Jamal HH; Kuzniar B; Klock RJ; Reis MD
Leukemia; 1993 Jan; 7(1):113-9. PubMed ID: 8418370
[TBL] [Abstract][Full Text] [Related]
37. Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas.
Streubel B; Scheucher B; Valencak J; Huber D; Petzelbauer P; Trautinger F; Weihsengruber F; Mannhalter C; Cerroni L; Chott A
Am J Surg Pathol; 2006 Apr; 30(4):529-36. PubMed ID: 16625101
[TBL] [Abstract][Full Text] [Related]
38. Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis.
Abdul-Wahab A; Tang SY; Robson A; Morris S; Agar N; Wain EM; Child F; Scarisbrick J; Neat M; Whittaker S
J Am Acad Dermatol; 2014 Jun; 70(6):1010-20. PubMed ID: 24679486
[TBL] [Abstract][Full Text] [Related]
39. The t(14;18) and bcl-2 expression are present in a subset of primary cutaneous follicular lymphoma: association with lower grade.
Lawnicki LC; Weisenburger DD; Aoun P; Chan WC; Wickert RS; Greiner TC
Am J Clin Pathol; 2002 Nov; 118(5):765-72. PubMed ID: 12428798
[TBL] [Abstract][Full Text] [Related]
40. Histological conversion of follicular lymphoma with structural alterations of t(14;18) and immunoglobin genes.
Raghoebier S; Broos L; Kramer MH; van Krieken JH; Kluin-Nelemans JC; van Ommen GJ; Kluin P
Leukemia; 1995 Oct; 9(10):1748-55. PubMed ID: 7564520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
